managed_entry

Managed Entry Agreements: The confidentiality issue

Managed Entry Agreements (MEAs) are contracts between pharmaceutical companies/…


biosimilar

Biosimilars: Enhancing physician uptake in the EU

At the moment, EU physicians seem much more comfortable than their US…


The curious case of biosimilar launches in the US

The Biologics Price Competition and Innovation Act (BPCI Act) of 2009 provided…